|
Apr 14
|
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
|
|
Mar 10
|
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 10
|
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
|
|
Mar 3
|
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
|
|
Feb 27
|
Spotlight On February 2025's Promising Penny Stocks
|
|
Feb 26
|
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
|
|
Feb 25
|
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
|
|
Feb 24
|
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
|
|
Feb 21
|
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
|
|
Feb 18
|
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
|
|
Jan 21
|
Anixa Biosciences CEO Provides Letter to Shareholders
|
|
Jan 17
|
Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges
|
|
Nov 8
|
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
|
|
Sep 30
|
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
|
|
Aug 26
|
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jul 29
|
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
|
|
Jul 26
|
We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely
|
|
Jul 23
|
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
|
|
Jul 23
|
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
|
|
Jun 24
|
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
|